Fabliha Chowdhury is a recent PhD graduate from the University of Pittsburgh School of Medicine. Her work focuses on evaluating molecular targets and signaling pathways to develop novel therapeutics for hematological disorders. She has a broad research background in benign and malignant hematopoiesis, red cell biology, and sickle cell disease. She loves to cook and watch cooking shows at her leisure.